CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2018 |
Sep. 30, 2017 |
Sep. 30, 2018 |
Sep. 30, 2017 |
|
| REVENUES: | ||||
| Total Revenues | $ 5,102,216 | $ 1,045,735 | $ 9,490,202 | $ 3,243,969 |
| COST OF REVENUES: | ||||
| Total Cost of Revenues | 2,773,862 | 658,391 | 5,428,037 | 1,875,280 |
| GROSS PROFIT | 2,328,354 | 387,344 | 4,062,165 | 1,368,689 |
| OPERATING EXPENSES: | ||||
| Selling and marketing expenses | 73,468 | 27,104 | 189,092 | 146,031 |
| Salaries, wages and contract labor | 1,072,029 | 784,012 | 3,153,138 | 2,359,899 |
| Research and development | 122,755 | 65,984 | 401,116 | 225,982 |
| Professional fees | 63,878 | 87,366 | 187,679 | 292,099 |
| General and administrative expenses | 359,991 | 210,398 | 864,969 | 768,606 |
| Total Operating Expenses | 1,692,121 | 1,174,864 | 4,795,994 | 3,792,617 |
| INCOME (LOSS) FROM OPERATIONS | 636,233 | (787,520) | (733,829) | (2,423,928) |
| OTHER INCOME (EXPENSES): | ||||
| Interest expense | (4,589) | (1,525,894) | (14,755) | (3,279,898) |
| Gain on settlement of debt | 64,647 | |||
| Warrant derivative gain | 2,188,546 | 1,901,219 | ||
| Other income, net | 981 | 3,742 | 1 | |
| Total Other Income (Expense) | (3,608) | 662,652 | (11,013) | (1,314,031) |
| NET INCOME (LOSS) | 632,625 | (124,868) | (744,842) | (3,737,959) |
| Series A preferred stock dividends | (5,920) | (17,760) | ||
| Net income (loss) applicable to common stock | $ 632,625 | $ (130,788) | $ (744,842) | $ (3,755,719) |
| Basic Net Income (Loss) Per Share | $ 0.03 | $ (0.07) | $ (0.04) | $ (1.98) |
| Diluted Net Income (Loss) Per Share | $ 0.02 | $ (0.07) | $ (0.04) | $ (1.98) |
| Weighted Average Shares-Basic | 20,752,450 | 1,899,716 | 20,724,153 | 1,896,578 |
| Weighted Average Shares-Diluted | 26,412,450 | 1,899,716 | 20,724,153 | 1,896,578 |
| Project Revenues [Member] | ||||
| REVENUES: | ||||
| Total Revenues | $ 4,731,106 | $ 561,022 | $ 8,516,812 | $ 1,512,628 |
| COST OF REVENUES: | ||||
| Total Cost of Revenues | 2,684,785 | 458,337 | 5,079,455 | 1,180,193 |
| Maintenance and Technical Support Revenues [Member] | ||||
| REVENUES: | ||||
| Total Revenues | 371,110 | 288,137 | 881,004 | 914,438 |
| COST OF REVENUES: | ||||
| Total Cost of Revenues | 89,077 | 131,363 | 300,593 | 366,357 |
| IT Asset Management Services Revenues [Member] | ||||
| REVENUES: | ||||
| Total Revenues | 196,576 | 92,386 | 816,903 | |
| COST OF REVENUES: | ||||
| Total Cost of Revenues | $ 68,691 | $ 47,989 | $ 328,730 | |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as other. No definition available.
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of income related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|